HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Simon Uzor Selected Research

TG 003

12/2021CDC2-like (CLK) protein kinase inhibition as a novel targeted therapeutic strategy in prostate cancer.
9/2018Autoregulation of the human splice factor kinase CLK1 through exon skipping and intron retention.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Simon Uzor Research Topics

Disease

3Neoplasms (Cancer)
12/2021 - 01/2018
3Prostatic Neoplasms (Prostate Cancer)
12/2021 - 01/2018
1Breast Neoplasms (Breast Cancer)
01/2018
1Hypoxia (Hypoxemia)
01/2018

Drug/Important Bio-Agent (IBA)

3Phosphotransferases (Kinase)IBA
12/2021 - 01/2018
2Protein Kinases (Protein Kinase)IBA
12/2021 - 09/2018
2TG 003IBA
12/2021 - 09/2018
1benzothiazoleIBA
12/2021
1Harmine (Telepathine)IBA
09/2018
1AlkaloidsIBA
09/2018
1Pharmaceutical PreparationsIBA
09/2018
1Caspase 9IBA
01/2018

Therapy/Procedure

1Therapeutics
01/2018